CG
ABEO icon

Cutler Group’s Abeona Therapeutics ABEO Stock Holding History

Cutler Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40
Closed -$3K – 3921
2019
Q4 		$3K Sell
40
-40
-50% -$2.82K ﹤0.01% 3227
2019
Q3 		$4K Hold
80
– – ﹤0.01% 3117
2019
Q2 		$9K Hold
80
– – ﹤0.01% 2718
2019
Q1 		$14K Hold
80
– – ﹤0.01% 2253
2018
Q4 		$14K Buy
+80
New +$17.4K ﹤0.01% 2328
2017
Q4 		– Sell
-680
Closed -$281K – 4767
2017
Q3 		$289K Buy
680
+580
+580% +$156K 0.01% 939
2017
Q2 		$16K Sell
100
-256
-72% -$34.9K ﹤0.01% 3633
2017
Q1 		$44K Buy
+356
New +$45.9K ﹤0.01% 2532
2016
Q4 		– Sell
-4
Closed – – 6396
2016
Q3 		$0 Sell
4
-8
-67% -$782 ﹤0.01% 6559
2016
Q2 		$0 Sell
12
-8
-40% -$547 ﹤0.01% 6532
2016
Q1 		$1K Hold
20
– – ﹤0.01% 5858
2015
Q4 		$1K Buy
+20
New +$2.01K ﹤0.01% 5811

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Cutler Group's ABEO Position: Q1 2020 in Review

Cutler Group sold out of Abeona Therapeutics (ABEO) in Q1 2020, closing a stake of 40 shares — an estimated $3K sold.

Cutler Group first reported a position in ABEO in Q4 2015 and held it in 12 quarters. The position peaked at $289K in Q3 2017. 80 funds tracked by Wall St. Rank hold ABEO as of Q1 2020.

  • Cutler Group reported no remaining Abeona Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 40 Abeona Therapeutics shares in Q1 2020, an estimated $3K.
  • Cutler Group first reported a position in Abeona Therapeutics in Q4 2015 and held it in 12 quarters.
  • Cutler Group's Abeona Therapeutics position peaked at $289K in Q3 2017.
  • 80 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.